Caliway Biopharmaceuticals Co Ltd(TW:6919)
NT$70.00-0.50 (-0.71%)
TW:6919
Caliway Biopharmaceuticals Co Ltd Revenue
NT$70.00
At close:-0.50 (-0.71%)
Caliway Biopharmaceuticals Co Ltd (6919) Revenue
Caliway Biopharmaceuticals Co Ltd Revenue
Caliway Biopharmaceuticals Co Ltd had a revenue of 3.57M in the quarter ending Jun 30, 2026, with 178289.19%. This bring the company's revenue in the last twelve months to 29.36M, Decreased 22.75%. In the fiscal year ending Dec 31, 2025, Caliway Biopharmaceuticals Co Ltd had annual revenue of 37.98M with -14.39% growth.
- Revenue (ttm)
- 29.36M
- Revenue Growth
- -54.34%
- P/S Ratio
- 2890.81
- Revenue/Employee
- TWD 1,898,796
- Employees
- 20
- Market Cap
- TWD 109.78B
Revenue Chart
Caliway Biopharmaceuticals Co Ltd Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 37.98M | -6.38M | -14.39% |
| Dec 31, 2024 | 44.36M | 5.48M | 14.08% |
| Dec 31, 2023 | 38.88M | 26.06M | 203.12% |
| Dec 31, 2022 | 12.83M | 505.24K | 4.10% |
| Dec 31, 2021 | 12.32M | 1.98M | 19.17% |
| Dec 31, 2020 | 10.34M | -8.29M | -44.51% |
| Dec 31, 2019 | 18.63M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.